New Assay Suggests Paxil May Promote Breast Tumors in Women

Feb 19, 2014

Los Angeles Times

Researchers from the City of Hope in Duarte have developed a quick way to identify drugs and chemicals that can disrupt the balance of sex hormones in humans and influence the development and progress of diseases such as breast cancer. In a trial screening of 446 drugs, the new assay singled out the antidepressant paroxetine (a/k/a Paxil) as having a weak estrogenic effect that could promote the development and growth of breast tumors in women. Read the full story

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments